Condition
Quadraplegia
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed2
Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05936619Not ApplicableRecruiting
MindEx: A Novel, Multifocal, Cognitive Brain-Machine Interface System
NCT05095454Not ApplicableCompleted
Short-Term Transcutaneous or Epidural Spinal Stimulation for Enabling Motor Function in Humans With SCI
NCT01707498Not ApplicableUnknownPrimary
Robust Intelligent Keyboard for Quadraplegic Patients
NCT01896037Phase 4Completed
Omega-3 Supplementation for Tetraplegics With Poor Cholesterol Levels
Showing all 4 trials